Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity C. J. SanchezT. Le TreutR. T. Costello Review 10 August 2010 Pages: 1 - 13
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond C. M. BrittenS. JanetzkiM. M. Davis Position paper Open access 16 November 2010 Pages: 15 - 22
MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes Valérie CessonJean-Paul RivalsPedro Romero Original Article 21 September 2010 Pages: 23 - 35
Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation Willemijn van den AnckerMarvin M. van LuijnArjan A. van de Loosdrecht Original Article Open access 22 September 2010 Pages: 37 - 47
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells Max WarnckeMaike BuchnerHendrik Veelken Original Article Open access 17 September 2010 Pages: 49 - 60
Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers Lei WuAnastasia PartonJ. Blake Bartlett Original Article 17 September 2010 Pages: 61 - 73
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia Franz Josef GassnerLukas WeissInge Tinhofer Original Article Open access 21 September 2010 Pages: 75 - 85
An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine R. Curtis BirdPatricia DeInnocentesBruce F. Smith Original Article 11 November 2010 Pages: 87 - 97
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model Hidenobu IshizakiEdwin R. ManuelJoshua D. I. Ellenhorn Original Article 20 October 2010 Pages: 99 - 109
Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes Yunyun SuEdwin K. JacksonElieser Gorelik Original Article 20 October 2010 Pages: 111 - 122
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival A. N. CornforthA. W. FowlerR. O. Dillman Original Article 20 October 2010 Pages: 123 - 131
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells Timothy J. HaggertyIan S. DunnJames T. Kurnick Original Article 30 October 2010 Pages: 133 - 144
CD4+ T cell response against a non-tumor antigen is unaffected in melanoma-bearing mice Ana Paula Duarte de SouzaThiago de Jesus BorgesCristina Bonorino Short communication 21 October 2010 Pages: 145 - 151
